cagrilintide and semaglutide 2.4 mg Coadministered in Adults with Overweight or Obesity Efficacy and safety of once-weekly

doi: 10.1016/j.phrs.2022.106320 74 AmorSPuentesFBakerDvan der ValkP

Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C, Claxton D, Donato M, Bruton J, Cohen A, Davis M, Andersson BS, Anderlini P, Gajewski J, Kornblau S, Andreeff M , Przepiorka D, Ueno NT, Molldrem J, Champlin R

Reviews 1,396 4.6 HSA/FSA Weight Loss A compounded GLP-1 injection containing semaglutide, designed to help manage appetite and support sustainable weight care while addressing underlying metabolic health factors for long-term results

doi: 10.2147/NDT.S260160 161 MaDLChenFQXuWJYueWZYuanGYangY

The high cost of GLP-1 plus the risk of inappropriate or unnecessary prescriptions requires GLP-1 coverage to be a structured process with checks and balances to ensure necessary and effective prescribing and avoid side effects that can result in early discontinuation

Serum Zinc Concentration in Patients with Alopecia Areata